Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bonmassar

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1970
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drugE Bonmassar, A Bonmassar, S Vadlamudi, et al.
Experientia|May 15, 1970
Primary antibody response in mice bearing leukemia L1210E Bonmassar, A Bonmassar, S Vadlamudi, et al.
International Journal of Cancer|January 15, 1971
Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (L1210) miceS Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Trends in Immunology|June 8, 2001
Drugs and the immune system: the emerging era of immunopharmacologyP Periti, L Romani, E Bonmassar, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
New preclinical models for testing antitumor drugs. The immuno-chemotherapy indexL Frati, C Riccardi, A Bartocci, et al.
Cancer|June 1, 1971
Immunologic response of mice bearing leukemia L1210E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Cancer Research|May 1, 1973
Depression of antilymphoma allograft reactivity by tumor-associated factorsE Bonmassar, A Bonmassar, A Goldin, et al.
Cancer Research|July 1, 1972
Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamideE Bonmassar, A Bonmassar, S Vadlamudi, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1970
Reduction of antileukemic and immunosuppressive activities of 5-azacytidine in mice by concurrent treatment with uridineS Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Cell Death and Differentiation|June 26, 2001
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cellsL Tentori, I Portarena, E Bonmassar, et al.
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1970
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drugE Bonmassar, A Bonmassar, S Vadlamudi, et al.
Experientia|May 15, 1970
Primary antibody response in mice bearing leukemia L1210E Bonmassar, A Bonmassar, S Vadlamudi, et al.
International Journal of Cancer|January 15, 1971
Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (L1210) miceS Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Trends in Immunology|June 8, 2001
Drugs and the immune system: the emerging era of immunopharmacologyP Periti, L Romani, E Bonmassar, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
New preclinical models for testing antitumor drugs. The immuno-chemotherapy indexL Frati, C Riccardi, A Bartocci, et al.
Cancer|June 1, 1971
Immunologic response of mice bearing leukemia L1210E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Cancer Research|May 1, 1973
Depression of antilymphoma allograft reactivity by tumor-associated factorsE Bonmassar, A Bonmassar, A Goldin, et al.
Cancer Research|July 1, 1972
Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamideE Bonmassar, A Bonmassar, S Vadlamudi, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1970
Reduction of antileukemic and immunosuppressive activities of 5-azacytidine in mice by concurrent treatment with uridineS Vadlamudi, M Padarathsingh, E Bonmassar, et al.
Cell Death and Differentiation|June 26, 2001
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cellsL Tentori, I Portarena, E Bonmassar, et al.
Pageof 19